Open beta · everything is free with an account while we build. Founding accounts get preferred pricing when paid plans arrive. Create yours →
NM

NICOLAS MAGALLANES

TODD STRATEGY GROUP · Washington, DC
Registered · LDAActive

At a glance

Works on
Professional highlights appear here once this profile is claimed. Claim it →

Background

Career
Washington, DC · current
Government experience
Senior Advisor - House Republican Conference; Policy Advisor/Professional Staff Member - U.S. Representative Lee Terry/Energy and Commerce Committee; Legislative Correspondent/Legislative Aide - U.S. Senator Lamar Alexander
Covered official positions, as disclosed on federal filings

The past 12 months

Clients
7
past 12 months
Filings
7
past 12 months
Agencies contacted
HOUSE OF REPRESENTATIVESSENATEHealth & Human Services, Dept of (HHS)Centers For Medicare and Medicaid Services (CMS)

Specific issues

Center for Medicare and Medicaid Innovation (CMMI) policy issues. Drug Pricing. General Medicare and Medicaid Issues. Implementation of Inflation Reduction Act of 2022. H.R.1672 - Maintaining Investments in New Innovation Act. S.3131 / H.R.5539 - ORPHAN Cures Act. S.832/H.R.1492: Ensuring Pathways to Innovative Cures Act of 2025 or the EPIC Act of 2025.
Medicare/Medicaid · 2026 Q2
Supply Chain. 340B Issues. Genetically Targeted Therapies. PBM policy issues. H.R.5376 - Inflation Reduction Act of 2022 implementation. Most Favored Nation (MFN) policy.
Health Issues · 2026 Q2
General discussions around Medicare/Medicaid. Implementation of IRA.
Medicare/Medicaid · 2026 Q2
Waste, fraud, and abuse.
Medicare/Medicaid · 2026 Q1
Alzheimer's Disease. Anti Obesity Medication.
Health Issues · 2026 Q2
Medicare/Medicaid Coverage and Reimbursement. PDUFA. 340B Program. Issues related to drug compounding.
Medicare/Medicaid · 2026 Q2

Clients

2026 · 1 filing
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
2026 · 1 filing
$██,███ / qtrFree in beta
$██,███ / qtrFree in beta

Sources

This profile is built from the public record: filings in the U.S. Senate Lobbying Disclosure Act system. lda.senate.gov ↗

Recent filings7
2026 Q2
NOVARTIS, INC.
Q2lda.gov →
2026 Q2
MENARINI GROUP
RRlda.gov →
2026 Q2
ELI LILLY AND COMPANY
Q2lda.gov →
2026 Q1
SUNBOUND HOMES
RRlda.gov →
2026 Q1
BIOGEN, INC.
Q1lda.gov →
2026 Q1
ALNYLAM PHARMACEUTICALS, INC.
Q1lda.gov →
2026 Q1
PFIZER INC.
Q1lda.gov →